KRMD logo

KORU Medical Systems Inc. (KRMD)

$3.69

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on KRMD

Market cap

$160054399

EPS

-0.02

P/E ratio

--

Price to sales

3.03

Dividend yield

--

Beta

0.465233

Price on KRMD

Previous close

$3.70

Today's open

$3.65

Day's range

$3.55 - $3.73

52 week range

$2.86 - $6.61

Profile about KRMD

CEO

Linda M. Tharby

Employees

73

Headquarters

Mahwah, NJ

Exchange

NASDAQ Capital Market

Shares outstanding

43375176

Issue type

Common Stock

KRMD industries and sectors

Healthcare

Medical Equipment & Supplies

News on KRMD

KORU Is On The Mend

KORU Medical Systems is rated Buy at $3.50, as Q3 results signal recovery from temporary headwinds. KRMD's FY26 guidance was raised, with revenue expected at $48.0M–$48.5M (17–18% growth) and gross margin at 63–64%. Core SCIg business remains strong (+11.2% y/y), gross margin expanded 500bp, and pipeline initiatives support future growth.

news source

Seeking Alpha • Nov 13, 2026

news preview

What KORU Medical Systems (KRMD) Said on Its Q3 Earnings Call

KORU Medical Systems NASDAQ: KRMD raised the lower end of its 2026 revenue and gross margin guidance after reporting third-quarter revenue growth of 11%, a second consecutive quarter of positive net income and new distribution agreements in Europe and Africa.

news source

MarketBeat • Nov 11, 2026

news preview

KORU Medical Systems, Inc. (KRMD) Q3 2026 Earnings Call Transcript

KORU Medical Systems, Inc. (KRMD) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 11, 2026

news preview

KORU Medical Systems Announces Third Quarter 2026 Results Including Second Consecutive Quarter of Positive Net Income and Adjusted EBITDA

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the third quarter ended September 30, 2026. Third Quarter 2026 and Recent Highlights Net revenues grew 11% over the prior year period to $11.6 million; year to date net rev.

news source

Business Wire • Nov 10, 2026

news preview

KORU Medical Systems to Participate in Upcoming Investor Conferences

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will participate in the following investor conference: Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum. Management is scheduled to present on Novembe.

news source

Business Wire • Nov 4, 2026

news preview

KORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report third quarter 2026 financial results on Tuesday, November 10, 2026. KORU Medical's management will host a conference call and webcast at 4:30 p.m. ET that day to discus.

news source

Business Wire • Oct 20, 2026

news preview

KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call Transcript

KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call Transcript

news source

Seeking Alpha • Aug 6, 2026

news preview

KORU Medical Systems Q2 Earnings Call Highlights

KORU Medical Systems NASDAQ: KRMD reported second-quarter revenue of $12 million, up 18% from a year earlier, as domestic patient starts, market-share gains and international demand supported growth. The company also said it achieved positive net income for the first time since 2019 and raised its full-year gross-margin outlook, while narrowing revenue guidance because certain international prefilled-syringe market launches are taking longer to develop than expected.

news source

MarketBeat • Aug 6, 2026

news preview

KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the second quarter ended June 30, 2026. The Company also updated guidance for the full year 2026. Second Quarter 2026 and Recent Highlights Net revenues grew 18% over the p.

news source

Business Wire • Aug 5, 2026

news preview

KORU Medical Systems, Inc. (KRMD) Q2 Earnings and Revenues Beat Estimates

KORU Medical Systems, Inc. (KRMD) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to break-even earnings per share a year ago.

news source

Zacks Investment Research • Aug 5, 2026

news preview

¹ Disclosures

Get started with M1

Invest in KORU Medical Systems Inc.

Open an M1 investment account to buy and sell KORU Medical Systems Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in KRMD on M1